The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved ...

Known for its innovative and patient-centered approach, the clinic serves as a leader in weight loss management ... The FDA's ...

Like Ozempic, Mounjaro is FDA-approved as a diabetes drug. It can help folks with type 2 diabetes ... Most insurance ...

The Food and Drug Administration told CBS News it cannot comment ... main ingredient semaglutide. FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and Zepbound, ...